PHC to transfer Ascensia Diabetes Care to Senseonic, accelerate growth of Eversense

TOKYO – PHC Holdings Corp. has announced that subsidiary Ascensia Diabetes Care has signed a memorandum of understanding to transfer the commercial operations for Eversense Continuous Glucose Monitoring (CGM) systems to Eversense maker Senseonics Holdings. The companies seek to unite Eversense R&D, manufacturing and commercial activities within Senseonics beginning Jan. 1, 2026, subject to a definitive agreement. The move would enable Eversense to accelerate growth and realize its full potential faster than under the current structure, they say. Following the signing of a definitive agreement, most of the Eversense commercial team at Ascensia, including Brian Hansen, president of CGM, who led the successful U.S. Eversense 365 launch, would transition to Senseonics. "We are very proud to have worked with Senseonics on commercializing Eversense and we are committed to supporting Senseonics in establishing their own commercial operations and smoothly transitioning to them when we have a definitive agreement,” said Koichiro Sato, COO and chief strategy officer of PHC Group and CEO of Ascensia. “PHC Group remains invested in Senseonics and will continue to explore additional growth opportunities in the diabetes space." PHC Group and Ascensia plan to transfer commercial operations for Eversense to Senseonics and utilize Transition Service Agreements as needed while Senseonics establishes its global infrastructure. The companies anticipate minimal disruption for business partners, patients and providers. Ascensia launched the Eversense 365 in 2024. "Eversense is truly differentiated from any other CGM system on the market, and we believe now is the time to bring manufacturing and commercialization together to allow Senseonics to grow and remain responsive to the future needs of people with diabetes,” said Tim Goodnow, president and CEO of Senseonics. “We truly appreciate the partnership and investment that PHC Group and Ascensia have made in Senseonics, and we look forward to welcoming the talented commercial team and continuing to build momentum for Eversense 365."